Loading…
Metabolite analysis of [18F]Florbetaben (BAY 94-9172) in human subjects: a substudy within a proof of mechanism clinical trial
[ 18 F]Florbetaben ([ 18 F]BAY 94-9172) is a promising β-amyloid (Aβ) targeted PET-tracer currently in late stage clinical development. [ 18 F]Florbetaben can assist in the more accurate diagnosis of Alzheimer’s Disease (AD) by non-invasive, in vivo detection of Aβ in the brain. To determine the art...
Saved in:
Published in: | Journal of radioanalytical and nuclear chemistry 2010-06, Vol.284 (3), p.557-562 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | cdi_FETCH-LOGICAL-p160t-7f1bf2878b6d8df9b94e912edcd1519bb0933d64c5311c5ed7b4673a70c39d1f3 |
container_end_page | 562 |
container_issue | 3 |
container_start_page | 557 |
container_title | Journal of radioanalytical and nuclear chemistry |
container_volume | 284 |
creator | Patt, M. Schildan, A. Barthel, H. Becker, G. Schultze-Mosgau, M. H. Rohde, B. Reininger, C. Sabri, O. |
description | [
18
F]Florbetaben ([
18
F]BAY 94-9172) is a promising β-amyloid (Aβ) targeted PET-tracer currently in late stage clinical development. [
18
F]Florbetaben can assist in the more accurate diagnosis of Alzheimer’s Disease (AD) by non-invasive, in vivo detection of Aβ in the brain. To determine the arterial input function of the PET tracer—as part of a proof of mechanism (PoM) study—arterial samples were drawn from all subjects at predefined time points post injection (p.i.), and the proportion of unchanged tracer [
18
F]Florbetaben was determined by HPLC analysis. Plasma metabolite profiles were investigated following intravenous administration of 300 MBq (±60 MBq) of [
18
F]Florbetaben to both, patients with AD and healthy controls (HCs), and various methods for processing the blood samples were evaluated. Addition of acetonitrile to plasma samples (obtained from whole blood by centrifugation) and precipitation of proteins resulted in a recovery of more than 90% of the initial radioactivity in the supernatants. High Performance Liquid Chromatography using a polymer-based column (PRP-1) in conjunction with gradient elution was found to be a suitable method of metabolite analysis of [
18
F]Florbetaben. HPLC analyses indicated that [
18
F]Florbetaben is rapidly metabolized in vivo with an estimated initial half-life of about 6 min. A polar metabolite fraction, consisting presumably of more than one component, and (to a smaller extent) of the demethylated derivative of [
18
F]Florbetaben were time-dependently detected in plasma. |
doi_str_mv | 10.1007/s10967-010-0514-8 |
format | article |
fullrecord | <record><control><sourceid>proquest_sprin</sourceid><recordid>TN_cdi_proquest_miscellaneous_902376517</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>902376517</sourcerecordid><originalsourceid>FETCH-LOGICAL-p160t-7f1bf2878b6d8df9b94e912edcd1519bb0933d64c5311c5ed7b4673a70c39d1f3</originalsourceid><addsrcrecordid>eNotkEFLwzAUx4MoOKcfwFtu6iGa17RN4m0Op8LEix5EJCRp6jKydjYpsouf3ZYJD96D_48_jx9C50CvgVJ-E4HKkhMKlNACciIO0AQKIUjGBT1EE5qxkhScwTE6iXFNKZVCsAn6fXZJmzb45LBudNhFH3Fb4w8Qi89FaDsz5q7Bl3ezdyxzIoFnV9g3eNVvdINjb9bOpniL9XjH1Fc7_OPTaiA03nbt0DXMxtmVbnzcYBt8460OOHVeh1N0VOsQ3dn_nqK3xf3r_JEsXx6e5rMl2UJJE-E1mDoTXJiyElUtjcydhMxVtoICpDFUMlaVuS0YgC1cxU1ecqY5tUxWULMputj3Dh999y4mtfHRuhB049o-Kjn44WUBfCCzPRm3nW--XKfWbd8NZqICqkbXau9aDa7V6FoJ9gf3eHGf</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>902376517</pqid></control><display><type>article</type><title>Metabolite analysis of [18F]Florbetaben (BAY 94-9172) in human subjects: a substudy within a proof of mechanism clinical trial</title><source>Springer Nature</source><creator>Patt, M. ; Schildan, A. ; Barthel, H. ; Becker, G. ; Schultze-Mosgau, M. H. ; Rohde, B. ; Reininger, C. ; Sabri, O.</creator><creatorcontrib>Patt, M. ; Schildan, A. ; Barthel, H. ; Becker, G. ; Schultze-Mosgau, M. H. ; Rohde, B. ; Reininger, C. ; Sabri, O.</creatorcontrib><description>[
18
F]Florbetaben ([
18
F]BAY 94-9172) is a promising β-amyloid (Aβ) targeted PET-tracer currently in late stage clinical development. [
18
F]Florbetaben can assist in the more accurate diagnosis of Alzheimer’s Disease (AD) by non-invasive, in vivo detection of Aβ in the brain. To determine the arterial input function of the PET tracer—as part of a proof of mechanism (PoM) study—arterial samples were drawn from all subjects at predefined time points post injection (p.i.), and the proportion of unchanged tracer [
18
F]Florbetaben was determined by HPLC analysis. Plasma metabolite profiles were investigated following intravenous administration of 300 MBq (±60 MBq) of [
18
F]Florbetaben to both, patients with AD and healthy controls (HCs), and various methods for processing the blood samples were evaluated. Addition of acetonitrile to plasma samples (obtained from whole blood by centrifugation) and precipitation of proteins resulted in a recovery of more than 90% of the initial radioactivity in the supernatants. High Performance Liquid Chromatography using a polymer-based column (PRP-1) in conjunction with gradient elution was found to be a suitable method of metabolite analysis of [
18
F]Florbetaben. HPLC analyses indicated that [
18
F]Florbetaben is rapidly metabolized in vivo with an estimated initial half-life of about 6 min. A polar metabolite fraction, consisting presumably of more than one component, and (to a smaller extent) of the demethylated derivative of [
18
F]Florbetaben were time-dependently detected in plasma.</description><identifier>ISSN: 0236-5731</identifier><identifier>EISSN: 1588-2780</identifier><identifier>DOI: 10.1007/s10967-010-0514-8</identifier><language>eng</language><publisher>Dordrecht: Springer Netherlands</publisher><subject>Chemistry ; Chemistry and Materials Science ; Diagnostic Radiology ; Hadrons ; Heavy Ions ; Inorganic Chemistry ; Nuclear Chemistry ; Nuclear Physics ; Physical Chemistry</subject><ispartof>Journal of radioanalytical and nuclear chemistry, 2010-06, Vol.284 (3), p.557-562</ispartof><rights>Akadémiai Kiadó, Budapest, Hungary 2010</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-p160t-7f1bf2878b6d8df9b94e912edcd1519bb0933d64c5311c5ed7b4673a70c39d1f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids></links><search><creatorcontrib>Patt, M.</creatorcontrib><creatorcontrib>Schildan, A.</creatorcontrib><creatorcontrib>Barthel, H.</creatorcontrib><creatorcontrib>Becker, G.</creatorcontrib><creatorcontrib>Schultze-Mosgau, M. H.</creatorcontrib><creatorcontrib>Rohde, B.</creatorcontrib><creatorcontrib>Reininger, C.</creatorcontrib><creatorcontrib>Sabri, O.</creatorcontrib><title>Metabolite analysis of [18F]Florbetaben (BAY 94-9172) in human subjects: a substudy within a proof of mechanism clinical trial</title><title>Journal of radioanalytical and nuclear chemistry</title><addtitle>J Radioanal Nucl Chem</addtitle><description>[
18
F]Florbetaben ([
18
F]BAY 94-9172) is a promising β-amyloid (Aβ) targeted PET-tracer currently in late stage clinical development. [
18
F]Florbetaben can assist in the more accurate diagnosis of Alzheimer’s Disease (AD) by non-invasive, in vivo detection of Aβ in the brain. To determine the arterial input function of the PET tracer—as part of a proof of mechanism (PoM) study—arterial samples were drawn from all subjects at predefined time points post injection (p.i.), and the proportion of unchanged tracer [
18
F]Florbetaben was determined by HPLC analysis. Plasma metabolite profiles were investigated following intravenous administration of 300 MBq (±60 MBq) of [
18
F]Florbetaben to both, patients with AD and healthy controls (HCs), and various methods for processing the blood samples were evaluated. Addition of acetonitrile to plasma samples (obtained from whole blood by centrifugation) and precipitation of proteins resulted in a recovery of more than 90% of the initial radioactivity in the supernatants. High Performance Liquid Chromatography using a polymer-based column (PRP-1) in conjunction with gradient elution was found to be a suitable method of metabolite analysis of [
18
F]Florbetaben. HPLC analyses indicated that [
18
F]Florbetaben is rapidly metabolized in vivo with an estimated initial half-life of about 6 min. A polar metabolite fraction, consisting presumably of more than one component, and (to a smaller extent) of the demethylated derivative of [
18
F]Florbetaben were time-dependently detected in plasma.</description><subject>Chemistry</subject><subject>Chemistry and Materials Science</subject><subject>Diagnostic Radiology</subject><subject>Hadrons</subject><subject>Heavy Ions</subject><subject>Inorganic Chemistry</subject><subject>Nuclear Chemistry</subject><subject>Nuclear Physics</subject><subject>Physical Chemistry</subject><issn>0236-5731</issn><issn>1588-2780</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><recordid>eNotkEFLwzAUx4MoOKcfwFtu6iGa17RN4m0Op8LEix5EJCRp6jKydjYpsouf3ZYJD96D_48_jx9C50CvgVJ-E4HKkhMKlNACciIO0AQKIUjGBT1EE5qxkhScwTE6iXFNKZVCsAn6fXZJmzb45LBudNhFH3Fb4w8Qi89FaDsz5q7Bl3ezdyxzIoFnV9g3eNVvdINjb9bOpniL9XjH1Fc7_OPTaiA03nbt0DXMxtmVbnzcYBt8460OOHVeh1N0VOsQ3dn_nqK3xf3r_JEsXx6e5rMl2UJJE-E1mDoTXJiyElUtjcydhMxVtoICpDFUMlaVuS0YgC1cxU1ecqY5tUxWULMputj3Dh999y4mtfHRuhB049o-Kjn44WUBfCCzPRm3nW--XKfWbd8NZqICqkbXau9aDa7V6FoJ9gf3eHGf</recordid><startdate>20100601</startdate><enddate>20100601</enddate><creator>Patt, M.</creator><creator>Schildan, A.</creator><creator>Barthel, H.</creator><creator>Becker, G.</creator><creator>Schultze-Mosgau, M. H.</creator><creator>Rohde, B.</creator><creator>Reininger, C.</creator><creator>Sabri, O.</creator><general>Springer Netherlands</general><scope>7TV</scope><scope>C1K</scope></search><sort><creationdate>20100601</creationdate><title>Metabolite analysis of [18F]Florbetaben (BAY 94-9172) in human subjects: a substudy within a proof of mechanism clinical trial</title><author>Patt, M. ; Schildan, A. ; Barthel, H. ; Becker, G. ; Schultze-Mosgau, M. H. ; Rohde, B. ; Reininger, C. ; Sabri, O.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p160t-7f1bf2878b6d8df9b94e912edcd1519bb0933d64c5311c5ed7b4673a70c39d1f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Chemistry</topic><topic>Chemistry and Materials Science</topic><topic>Diagnostic Radiology</topic><topic>Hadrons</topic><topic>Heavy Ions</topic><topic>Inorganic Chemistry</topic><topic>Nuclear Chemistry</topic><topic>Nuclear Physics</topic><topic>Physical Chemistry</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Patt, M.</creatorcontrib><creatorcontrib>Schildan, A.</creatorcontrib><creatorcontrib>Barthel, H.</creatorcontrib><creatorcontrib>Becker, G.</creatorcontrib><creatorcontrib>Schultze-Mosgau, M. H.</creatorcontrib><creatorcontrib>Rohde, B.</creatorcontrib><creatorcontrib>Reininger, C.</creatorcontrib><creatorcontrib>Sabri, O.</creatorcontrib><collection>Pollution Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><jtitle>Journal of radioanalytical and nuclear chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Patt, M.</au><au>Schildan, A.</au><au>Barthel, H.</au><au>Becker, G.</au><au>Schultze-Mosgau, M. H.</au><au>Rohde, B.</au><au>Reininger, C.</au><au>Sabri, O.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Metabolite analysis of [18F]Florbetaben (BAY 94-9172) in human subjects: a substudy within a proof of mechanism clinical trial</atitle><jtitle>Journal of radioanalytical and nuclear chemistry</jtitle><stitle>J Radioanal Nucl Chem</stitle><date>2010-06-01</date><risdate>2010</risdate><volume>284</volume><issue>3</issue><spage>557</spage><epage>562</epage><pages>557-562</pages><issn>0236-5731</issn><eissn>1588-2780</eissn><abstract>[
18
F]Florbetaben ([
18
F]BAY 94-9172) is a promising β-amyloid (Aβ) targeted PET-tracer currently in late stage clinical development. [
18
F]Florbetaben can assist in the more accurate diagnosis of Alzheimer’s Disease (AD) by non-invasive, in vivo detection of Aβ in the brain. To determine the arterial input function of the PET tracer—as part of a proof of mechanism (PoM) study—arterial samples were drawn from all subjects at predefined time points post injection (p.i.), and the proportion of unchanged tracer [
18
F]Florbetaben was determined by HPLC analysis. Plasma metabolite profiles were investigated following intravenous administration of 300 MBq (±60 MBq) of [
18
F]Florbetaben to both, patients with AD and healthy controls (HCs), and various methods for processing the blood samples were evaluated. Addition of acetonitrile to plasma samples (obtained from whole blood by centrifugation) and precipitation of proteins resulted in a recovery of more than 90% of the initial radioactivity in the supernatants. High Performance Liquid Chromatography using a polymer-based column (PRP-1) in conjunction with gradient elution was found to be a suitable method of metabolite analysis of [
18
F]Florbetaben. HPLC analyses indicated that [
18
F]Florbetaben is rapidly metabolized in vivo with an estimated initial half-life of about 6 min. A polar metabolite fraction, consisting presumably of more than one component, and (to a smaller extent) of the demethylated derivative of [
18
F]Florbetaben were time-dependently detected in plasma.</abstract><cop>Dordrecht</cop><pub>Springer Netherlands</pub><doi>10.1007/s10967-010-0514-8</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0236-5731 |
ispartof | Journal of radioanalytical and nuclear chemistry, 2010-06, Vol.284 (3), p.557-562 |
issn | 0236-5731 1588-2780 |
language | eng |
recordid | cdi_proquest_miscellaneous_902376517 |
source | Springer Nature |
subjects | Chemistry Chemistry and Materials Science Diagnostic Radiology Hadrons Heavy Ions Inorganic Chemistry Nuclear Chemistry Nuclear Physics Physical Chemistry |
title | Metabolite analysis of [18F]Florbetaben (BAY 94-9172) in human subjects: a substudy within a proof of mechanism clinical trial |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T23%3A36%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_sprin&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Metabolite%20analysis%20of%20%5B18F%5DFlorbetaben%20(BAY%2094-9172)%20in%20human%20subjects:%20a%20substudy%20within%20a%20proof%20of%20mechanism%20clinical%20trial&rft.jtitle=Journal%20of%20radioanalytical%20and%20nuclear%20chemistry&rft.au=Patt,%20M.&rft.date=2010-06-01&rft.volume=284&rft.issue=3&rft.spage=557&rft.epage=562&rft.pages=557-562&rft.issn=0236-5731&rft.eissn=1588-2780&rft_id=info:doi/10.1007/s10967-010-0514-8&rft_dat=%3Cproquest_sprin%3E902376517%3C/proquest_sprin%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p160t-7f1bf2878b6d8df9b94e912edcd1519bb0933d64c5311c5ed7b4673a70c39d1f3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=902376517&rft_id=info:pmid/&rfr_iscdi=true |